期刊文献+

尿路感染常见病原菌分布及耐药性分析 被引量:10

Distribution and drug resistance of common species of pathogens causing urinary tract infections
原文传递
导出
摘要 目的了解医院尿路感染病原菌分布特点及其耐药性,为临床合理选用抗菌药物提供依据。方法应用MicroSCAN4AutoSCAN鉴定药敏系统进行细菌鉴定和药敏试验,药敏结果使用WHO提供的WHONET5.4软件进行数据统计处理。结果 2007年1月-2011年12月共收集病原菌1808株,其中革兰阴性杆菌1289株占71.3%,革兰阳性球菌316株占17.5%,真菌203株占11.2%;分离率最高的病原菌为大肠埃希菌953株占52.7%,其次为肠球菌属246株占13.6%;产ESBLs大肠埃希菌的检出率为44.1%,大肠埃希菌对亚胺培南、头孢西丁、替卡西林/克拉维酸、哌拉西林/他唑巴坦、阿莫西林/克拉维酸和阿米卡星仍具有较高的抗菌活性,其耐药率<10.0%;铜绿假单胞菌对多数药物的耐药率<20.0%,耐亚胺培南铜绿假单胞菌的检出率为12.3%;检出5株耐万古霉素肠球菌;耐高浓度庆大霉素粪肠球菌和屎肠球菌检出率分别为58.5%和70.5%。结论泌尿系统感染的病原菌以大肠埃希菌为主,各菌种多药耐药性较为严重,临床应在细菌药物敏感性试验结果的指导下,合理应用抗菌药物,以减少耐药菌的发生。 OBJECTIVE To investigate the distribution and drug resistance of pathogens causing urinary tract infec-tions so as to provide evidence for rational use of antibiotics. METHODS The bacterial identification and antimicro-bial susceptibility testing were performed by MicroSCAN4 AutoSCAN system, and the data of the antibiotics susceptibility testing were statistically analyzed with the use of WHONET 5.4 software specified by the WHO. RESULTS A total of 1808 strains of pathogens have been isolated from Jan 2007 to Dec 2011, among which there were 1289 (71. 3%) strains of gram-negative bacilli, 316 (17. 5%) strains of gram-positive cocci, and 203 (11.2%) strains of fungil the isolation rate of Escherichia coli was the highest (52.7%, 953 strains), followed by Enterococcus (13.6%, 246 strains) ; the detection rate of the ESBLs-producing E. coli was 44.1%. The drug resistance rates of E. coli to imipenem, cefoxitin, ticarcillin-clavulanie acid, piperacillin-tazobactam, amoxicillin- clavulanic acid, and amikaein were less than 10.0% ; the drug resistance rates of the P. aeruginosa strains to most of the antibiotics were less than 20. 0%, the detection rate of imipenem-resistant P. aeruginosa was 12. 3% totally 5 strains of vancomycin-resistant Enterococcus have been detected; the detection rates of the high-concen-tration gentamicin-resistant Enterococcus faecalis and Enterococcus faecium were 58.5 % and 70.5 %, respective- ly. CONCLUSION The E. coli is the predominant species of pathogen causing the urinary tract infection, the pathogens are highly multidrug-resistant, thus it is necessary for the hospital to reasonably use antibiotics based on the result of drug susceptibility testing so as to reduce the occurrence of drug resistant strains.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第23期5857-5859,共3页 Chinese Journal of Nosocomiology
基金 广西壮族自治区科学技术厅基金项目(桂科攻1140003A-43) 广西壮族自治区卫生厅基金项目(Z2011497)
关键词 尿路感染 病原菌 抗菌药物 分布 耐药性 Urinary tract infection Pathogenic bacteria Antibiotic Distribution Drug resistance
  • 相关文献

参考文献4

二级参考文献29

  • 1张波,府伟灵,张晓兵,廖杨.尿路感染患者的病原菌分布及其耐药性[J].中华医院感染学杂志,2006,16(11):1291-1293. 被引量:57
  • 2王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Fifteenth Information Sup- plement[S]. M100-S20. CLSI,2010.
  • 4Calbo E,Romani V,Xercavins M,et al. Risk factors for com- munity-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases[J]. J Antimi- crob Chemother, 2006,57 (4): 780-783.
  • 5Qi Y, Wei Z, Li L,et al. Detection of a common plasmid carry- ing blaKPC-2 in Enterobacteriaceae isolates from distinct cities in China[J]. Microb Drug Resist,2010,16(4):297-301.
  • 6Wei ZQ, Du XX, Yu YS,et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China [J]. Antimierob Agents Chemother, 2007,51(2) : 763-765.
  • 7Qi Y,Wei Z,Ji S,et al. STll, the dominant clone of KPC- producing Klebsiella pneumoniae in China[J]. J Antimicrob Chemother, 2011,66(2) : 307-312.
  • 8Jeffres MN, Shuster JE,Barclay SM. Treatment of ciprofloxa- cin nonsusceptible urinary tract infections with ciprofloxacin [J]. Ann Pharmacother,2011,45(6) :824-825.
  • 9Stein GE,Schooley SL,Nicolau DP. Urinary bactericidal activ- ity of single doses (250, 500, 750 and 1000 mg) of levofloxa- cin against fluoroquinolone-resistant strains of Escherichia coli [J]. Int J Antimicrob Agents,2008,32(4) :320-325.
  • 10Minardi D, d'Anzeo G, Cantoro D,et al. Urinary tract infec- tions in women:etiology and treatment options[J]. Int J Gen Med, 2011,4 : 333-343.

共引文献132

同被引文献84

  • 1泌尿系结石诊治指南解读(二):肾结石治疗[J].泌尿外科杂志(电子版),2012(1):46-48. 被引量:63
  • 2张剑,邢月明.氟哌酸单剂顿服治疗下尿路感染的体会[J].山西医学院学报,1995,26(2):127-128. 被引量:2
  • 3齐仁立,张慧茹,崔斓斓.蒲公英抑菌成分提取工艺的优化[J].安徽农业科学,2007,35(17):5038-5039. 被引量:16
  • 4柏雪莲,宓伟,王志强,邱世翠,王冬.地锦草体外抑菌作用研究[J].时珍国医国药,2007,18(11):2747-2747. 被引量:15
  • 5Mohammad- Jafari H, Saffar M J, Nemate, et al. Increasing antibiotic resistance among uropathogens isolated during years 2006-2009: Impact on the empirical management [ J ]. Int Braz J Urol, 2012, 38(1): 25-32.
  • 6Wang H, Min G, Glockshuber R, et al. Uropathogenic E. coli adhesion-induced host cell receptor conformational changes: implications in transmembrane signaling transduction [ J ]. J Mol Biol, 2009, 392(2) : 352-361.
  • 7Chen PC, Chang LY, Lu CY, et al. Drug susceptibility and treatment response of common urinary tract infection pathogens in children [J]. J Microbiol Immunol Infect. 2013. doi: 10. 1016/ j. jmii. 2013.07.011.
  • 8E1-Gamal MI, Oh CH. Current status of carbapenem antibiotics [J]. Curt Top Med Chem, 2010, 10(18): 1882-1897.
  • 9Booth JL, Mullen AB, Thomson DA, et al. Antibiotic treatment of urinary tract infection by community pharmacists: a cross- sectional study [J]. Br J Gen Pract, 2013, 63(609): 244- 249.
  • 10Purvis S,Gion T,Kennedy G,et al.Catheter-associated urinary tract infection:a successful prevention effort employing a multipronged initiative at an academic medical center[J].J Nurs Care Qual,014,29(2):141-148.

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部